Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus-Reference-Cited by-同舟云学术

Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

Published:2009-05-31 Issue:7 Volume:10 Page:778-785
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Doreau Agnès,Belot Alexandre,Bastid Jérémy,Riche Benjamin,Trescol-Biemont Marie-Claude,Ranchin Bruno,Fabien Nicole,Cochat Pierre,Pouteil-Noble Claire,Trolliet Pierre,Durieu Isabelle,Tebib Jacques,Kassai Berhouz,Ansieau Stéphane,Puisieux Alain,Eliaou Jean-François,Bonnefoy-Bérard Nathalie

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.1741.pdf

Reference48 articles.

1. Yurasov, S., Hammersen, J., Tiller, T., Tsuiji, M. & Wardemann, H. B-cell tolerance checkpoints in healthy humans and patients with systemic lupus erythematosus. Ann. NY Acad. Sci. 1062, 165–174 (2005).

2. Meffre, E. & Wardemann, H. B-cell tolerance checkpoints in health and autoimmunity. Curr. Opin. Immunol. 20, 632–638 (2008).

3. Groom, J. & Mackay, F. B cells flying solo. Immunol. Cell Biol. 86, 40–46 (2008).

4. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449–1456 (1995).

5. Nagata, S. & Suda, T. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39–43 (1995).

Cited by 380 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of antiphospholipid autoantibodies associated with biologics treatment for psoriasis;Scientific Reports;2024-07-10

2. Molecular consideration relevant to the mechanism of the comorbidity between psoriasis and systemic lupus erythematosus (Review);Experimental and Therapeutic Medicine;2023-08-29

3. New-age vaccine adjuvants, their development, and future perspective;Frontiers in Immunology;2023-02-24

4. Systemic Lupus Erythematosus;Clinical Immunology;2023

5. Decreased SUV39H1 at the promoter region leads to increased CREMα and accelerates autoimmune response in CD4+ T cells from patients with systemic lupus erythematosus;Clinical Epigenetics;2022-12